These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins]. Ivanov KK Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748 [No Abstract] [Full Text] [Related]
7. Conjugate vaccines against Pseudomonas aeruginosa and malaria. Cryz SJ; Sadoff JC; Que JU Contrib Microbiol Immunol; 1989; 10():166-89. PubMed ID: 2510972 [No Abstract] [Full Text] [Related]
8. Vaccination against the cholera/coli family of enterotoxins by synthetic peptides. Jacob CO Adv Biotechnol Processes; 1990; 13():223-54. PubMed ID: 1692224 [No Abstract] [Full Text] [Related]
9. Estimation of Vibrio cholerae and Escherichia coli heat-labile enterotoxin by enzyme-linked immunosorbent assay (ELISA). Kétyi I; Pácsa AS Acta Microbiol Acad Sci Hung; 1980; 27(1):89-97. PubMed ID: 6998259 [TBL] [Abstract][Full Text] [Related]
10. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Rappuoli R; Pizza M; Douce G; Dougan G Immunol Today; 1999 Nov; 20(11):493-500. PubMed ID: 10529776 [No Abstract] [Full Text] [Related]
11. Synthetic peptides as the basis for vaccine design. Arnon R Mol Immunol; 1991 Mar; 28(3):209-15. PubMed ID: 2017193 [No Abstract] [Full Text] [Related]
12. Antibody titers of the commercially available human immunoglobulins against bacterial toxins and some opportunistic pathogens. Arai T; Komatsu S Kitasato Arch Exp Med; 1984 Sep; 57(3):243-6. PubMed ID: 6443134 [No Abstract] [Full Text] [Related]
13. Synthetic peptides with antigenic specificity for bacterial toxins. Sela M; Arnon R; Jacob CO Ciba Found Symp; 1986; 119():184-99. PubMed ID: 2426052 [TBL] [Abstract][Full Text] [Related]
15. Present situation and prospectives of influenza and cholera toxin vaccine. Arnon R Ann Sclavo Collana Monogr; 1984; 1(2):163-75. PubMed ID: 6400357 [No Abstract] [Full Text] [Related]
16. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus]. Kolb E Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175 [TBL] [Abstract][Full Text] [Related]
17. Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli. Aminian M; Sivam S; Lee CW; Halperin SA; Lee SF Protein Expr Purif; 2007 Feb; 51(2):170-8. PubMed ID: 16950635 [TBL] [Abstract][Full Text] [Related]
18. Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan. Horiuchi Y; Takahashi M; Konda T; Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y Jpn J Infect Dis; 2001 Oct; 54(5):167-80. PubMed ID: 11754154 [TBL] [Abstract][Full Text] [Related]
19. Preparation of vaccines by the action of glutaraldehyde on toxins, bacteria, viruses, allergens, and cells. Relyveld EH; Ben-Efraim S Methods Enzymol; 1983; 93():24-60. PubMed ID: 6306393 [No Abstract] [Full Text] [Related]
20. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine. Tamura SI; Kurata T Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]